Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DMTX Dimension Therapeutics Announces Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease
http://ih.advfn.com/p.php?pid=nmona&article=72587537
DMTX Dimension Therapeutics Announces Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease
http://ih.advfn.com/p.php?pid=nmona&article=72587537
DMTX Dimension Therapeutics Announces Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease
http://ih.advfn.com/p.php?pid=nmona&article=72587537
DMTX Dimension Therapeutics Announces Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease
http://ih.advfn.com/p.php?pid=nmona&article=72587537
DMTX NEWS OUT NOW Orphan drug status
http://ih.advfn.com/p.php?pid=nmona&article=72587537
there's the news...
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
link to FDA website... https://www.accessdata.fda.gov/scripts/opdlisting/oopd/
just do a search for sept 28 to find the designation
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
link to FDA website... https://www.accessdata.fda.gov/scripts/opdlisting/oopd/
just do a search for sept 28 to find the designation
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
link to FDA website... https://www.accessdata.fda.gov/scripts/opdlisting/oopd/
just do a search for sept 28 to find the designation
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
link to FDA website... https://www.accessdata.fda.gov/scripts/opdlisting/oopd/
just do a search for sept 28 to find the designation
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
link to FDA website... https://www.accessdata.fda.gov/scripts/opdlisting/oopd/
just do a search for sept 28 to find the designation
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
link to FDA website... https://www.accessdata.fda.gov/scripts/opdlisting/oopd/
just do a search for sept 28 to find the designation
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
It sure is. This is a $200-$500 stock in a couple of years.
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet... no pr. we're early
liver drug
DMTX drug granted orphan drug status
from FDA website
recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC)Treatment of glycogen storage disease type Ia (von Gierke Disease) 09/28/2016 Designated
This hasn't hit the news yet...
liver drug
Just wish I owned more of this...
NVIV
NVIV Spinal cord repair! Put this one on your radar.
This man had a spinal bridge implanted 2 months ago after severing his spinal cord in an accident. I expect this will skyrocket once the hospital/company make an official announcement regarding Jordan's progress.
http://microcapresearch.com/invivo-therapeutics-jordan-lee-fallis/
NVIV news -InVivo Therapeutics Announces FDA Approval to Expedite Enrollment for Ongoing Pilot Trial
http://ih.advfn.com/p.php?pid=nmona&article=64813591&symbol=NVIV
NVIV is set to gap up on open today.
If that gap fills, $1.05.
The 200MA is support at $1.23. That might be a good price to take a small position (if you don't already have one) if you want to hedge against the gap not filling.
If $1.23 doesn't hold, there should be support at the middle Bollinger Band which is $1.16, that's before the $1.05 gap-fill.
NVIV
Loving the volume and again it's mostly buying. Is PXYN finally getting the attention it deserves?
GV $2.47 target then $2.75
RELEASE THE Q! PXYN
From the last Q.
Some dd on this stock.
I was looking at the success they had with their animal testing regarding this procedure.
From here. http://invivotherapeutics.com/pdf/Teng_Langer_Polymer_StemCell_2002.pdf
Using the scaffold along with cell therapy they seemed to have excellent results.
A charting question about gaps. I'm looking at a chart (apologies, I don't have the means to post it here) that gapped down from a close on May 5th of $1.75 [traded as low as $1.62 that day] and opened the next day at $1.09 with a daily high of $1.21. Since then, the stock declined and then traded sideways. Recently there have been two gap ups, neither of which have filled. The stock has never recovered enough to hit $1.62 or $1.75, the gap down never filled.
My question, does the gap down which never filled, negate the need for the gaps up to fill?
Thank you Ospreyeye or any chartist who can help me with this!
Cheers,
B.
the gap from the 12th may be filling here... If so what a great buy opportunity.
$30 million market cap here. It's insane. That is one month of net revenues. And we are still growing...
PXYN
Yup, RSI and MFI need to cool a bit. Looking back on the chart there are the 2 unfilled gap ups but also a previous gap down, which never filled either.
It's likely there will be some consolidation now but I believe the uptrend is clear.
NVIV
NVIV Barchart says buy... http://www.barchart.com/opinions/stocks/NVIV
enormous potential here.
Nice $145000 buy just now. She's looking strong. NVIV
Wow what a story here!
Can anyone provide me with info on the share structure? TIA.
NVIV
PXYN about to hit blue sky territory. The company has experienced huge growth and is heading to earnings. A $30 million market cap is puny for this company which is doing over $1 million a day in business.
Real company with real revs here.
PXYN running into earnings (Friday).
Huge revenues coming for this rapidly growing company.
PXYN is about to break out on expectations of a huge quarterly report.
Do some DD on this one it's deeply undervalued.
A leetle more volume and we're in the 8's. It's all buys today.
PXYN
So excited for the Q. I hope they drop it tomorrow.